Bafna Pharmaceuticals reports standalone net profit of Rs 28.09 crore in the December 2017 quarter

Sales decline 31.61% to Rs 10.86 crore

Net profit of Bafna Pharmaceuticals reported to Rs 28.09 crore in the quarter ended December 2017 as against net loss of Rs 3.44 crore during the previous quarter ended December 2016. Sales declined 31.61% to Rs 10.86 crore in the quarter ended December 2017 as against Rs 15.88 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales10.8615.88 -32 OPM %5.06-0.76 -PBDT29.08-2.47 LP PBT28.09-3.49 LP NP28.09-3.44 LP

Powered by Capital Market - Live News